[ Price : $8.95]
As families sit down for Thanksgiving meals, the Alliance for a Stronger FDA says consideration should be given to FDA staff for t...[ Price : $8.95]
University of Tokyo researchers say that adverse events reports submitted to FDA vary in completeness depending on the occupation ...[ Price : $8.95]
Bloomberg News says the federal government and several generic drug companies have been in discussions to resolve an ongoing antit...[ Price : $8.95]
Spherix Global Insights says FDA approval of a new indication for Janssens Type 2 diabetes drug Invokana to slow the progression o...[ Price : $8.95]
FDA names Kaveeta Visisht to be associate commissioner for womens health.[ Price : $8.95]
FDA warns Lohxa LLC about CGMP violations in its production of finished pharmaceuticals.[ Price : $8.95]
A Center for Disease Control and Prevention report says that healthcare-associated infections resulting from medical devices are m...[ Price : $8.95]
CymaBay Therapeutics terminates a Phase 2b study of seladelpar in subjects with non-alcoholic steatohepatitis and its recently ini...